Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS GSK PHARMA IPCA LABS/
GSK PHARMA
 
P/E (TTM) x 47.8 63.7 74.9% View Chart
P/BV x 5.0 19.3 25.7% View Chart
Dividend Yield % 0.3 1.6 21.8%  

Financials

 IPCA LABS   GSK PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-23
GSK PHARMA
Mar-23
IPCA LABS/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0621,684 63.1%   
Low Rs7681,231 62.4%   
Sales per share (Unadj.) Rs243.0191.9 126.6%  
Earnings per share (Unadj.) Rs19.435.9 54.1%  
Cash flow per share (Unadj.) Rs29.739.8 74.7%  
Dividends per share (Unadj.) Rs4.0032.00 12.5%  
Avg Dividend yield %0.42.2 19.9%  
Book value per share (Unadj.) Rs230.3102.9 223.8%  
Shares outstanding (eoy) m253.70169.41 149.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.87.6 49.6%   
Avg P/E ratio x47.240.6 116.1%  
P/CF ratio (eoy) x30.836.7 84.0%  
Price / Book Value ratio x4.014.2 28.1%  
Dividend payout %20.689.2 23.1%   
Avg Mkt Cap Rs m232,120246,858 94.0%   
No. of employees `000NANA-   
Total wages/salary Rs m12,8765,950 216.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,64232,517 189.6%  
Other income Rs m1,5181,007 150.8%   
Total revenues Rs m63,16033,524 188.4%   
Gross profit Rs m9,0338,033 112.4%  
Depreciation Rs m2,616658 397.7%   
Interest Rs m48218 2,659.5%   
Profit before tax Rs m7,4538,364 89.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5342,288 110.8%   
Profit after tax Rs m4,9196,076 81.0%  
Gross profit margin %14.724.7 59.3%  
Effective tax rate %34.027.4 124.3%   
Net profit margin %8.018.7 42.7%  
BALANCE SHEET DATA
Current assets Rs m51,89324,943 208.0%   
Current liabilities Rs m18,05813,264 136.1%   
Net working cap to sales %54.935.9 152.8%  
Current ratio x2.91.9 152.8%  
Inventory Days Days5197 52.6%  
Debtors Days Days6216 2.7%  
Net fixed assets Rs m34,3366,988 491.4%   
Share capital Rs m2541,694 15.0%   
"Free" reserves Rs m58,16715,735 369.7%   
Net worth Rs m58,42017,430 335.2%   
Long term debt Rs m6,5180-   
Total assets Rs m86,22931,930 270.1%  
Interest coverage x16.5462.6 3.6%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.71.0 70.2%   
Return on assets %6.319.1 32.8%  
Return on equity %8.434.9 24.2%  
Return on capital %12.248.1 25.4%  
Exports to sales %42.90-   
Imports to sales %13.348.1 27.6%   
Exports (fob) Rs m26,434NA-   
Imports (cif) Rs m8,17815,630 52.3%   
Fx inflow Rs m26,4341,622 1,630.1%   
Fx outflow Rs m8,17815,630 52.3%   
Net fx Rs m18,257-14,008 -130.3%   
CASH FLOW
From Operations Rs m8,0584,842 166.4%  
From Investments Rs m-7,2508,079 -89.7%  
From Financial Activity Rs m5,072-15,433 -32.9%  
Net Cashflow Rs m5,881-2,512 -234.1%  

Share Holding

Indian Promoters % 46.3 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 44.8 11.6 386.8%  
FIIs % 10.3 2.9 350.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 25.0 214.8%  
Shareholders   82,809 114,663 72.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on IPCA Labs vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs GSK Pharma Share Price Performance

Period IPCA Labs GSK Pharma S&P BSE HEALTHCARE
1-Day -1.93% 0.62% -1.63%
1-Month -6.81% -11.78% -5.66%
1-Year 46.40% 55.26% 56.40%
3-Year CAGR 7.51% 11.56% 17.88%
5-Year CAGR 19.97% 8.71% 18.72%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.